MRKR director files Form 3, reports no beneficial ownership
Marker Therapeutics (MRKR) filed a Form 3 reporting the initial beneficial ownership for a director as of 10/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marker Therapeutics (MRKR) filed a Form 3 reporting the initial beneficial ownership for a director as of 10/31/2025. The filing states that no securities are beneficially owned.
The form was signed by /s/ Julio C. Esquivel as attorney-in-fact for Kathryn Penkus Corzo, pursuant to a power of attorney dated October 15, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Marker Therapeutics (MRKR) file?
Who is the reporting person on the MRKR Form 3?
What is the event date on the MRKR Form 3?
How many MRKR securities are reported as beneficially owned?
Who signed the MRKR Form 3 and under what authority?
What is the reporting person’s relationship to Marker Therapeutics?
AI-generated analysis. How Rhea-AI works. Not financial advice.